Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2009 1
2010 1
2011 1
2013 1
2014 1
2017 1
2020 2
2021 5
2022 8
2023 4
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership. Lattanzi S, et al. CNS Drugs. 2021 Dec;35(12):1289-1301. doi: 10.1007/s40263-021-00856-3. Epub 2021 Sep 2. CNS Drugs. 2021. PMID: 34476770 Free PMC article. Clinical Trial.
Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review.
Biagianti B, Di Liberto A, Nicolò Edoardo A, Lisi I, Nobilia L, de Ferrabonc GD, Zanier ER, Stocchetti N, Brambilla P. Biagianti B, et al. Among authors: di liberto a. Front Aging Neurosci. 2022 Jul 1;14:909661. doi: 10.3389/fnagi.2022.909661. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35847679 Free PMC article. Review.
Feasibility and preliminary efficacy of brief tele-psychotherapy for COVID-19 patients and their first-degree relatives.
Biagianti B, Lisi I, Di Liberto A, Turtulici N, Foti G, Zito S, Ginex V, Fornoni C, Gallo F, Cantù F, Tombola V, Di Fede V, Rossetti MG, Colombo E, Stocchetti N, Zanier ER, Bellani M, Bressi C, Brambilla P. Biagianti B, et al. Among authors: di liberto a. J Affect Disord. 2023 Jun 1;330:300-308. doi: 10.1016/j.jad.2023.03.024. Epub 2023 Mar 17. J Affect Disord. 2023. PMID: 36934855 Free PMC article. Review.
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.
Lattanzi S, Ascoli M, Canafoglia L, Paola Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group. Lattanzi S, et al. Epilepsia. 2022 May;63(5):e42-e50. doi: 10.1111/epi.17223. Epub 2022 Mar 26. Epilepsia. 2022. PMID: 35278335 Free PMC article.
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
Parisi M, Dogliotti I, Clerico M, Bertuzzo D, Benevolo G, Orsucci L, Schiavetti I, Cavallo R, Cavallo F, Ragaini S, Di Liberto A, Ferrante M, Bondielli G, Artusi CA, Drandi D, Lopiano L, Ferrero B, Ferrero S. Parisi M, et al. Among authors: di liberto a. Eur J Neurol. 2022 Dec;29(12):3611-3622. doi: 10.1111/ene.15553. Epub 2022 Sep 25. Eur J Neurol. 2022. PMID: 36083713 Free PMC article.
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST).
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership. Lattanzi S, et al. Drugs Aging. 2022 Apr;39(4):297-304. doi: 10.1007/s40266-022-00931-4. Epub 2022 Mar 28. Drugs Aging. 2022. PMID: 35344198 Free PMC article.
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy.
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST (Brivaracetam Add‐On First Italian Network Study) Group Membership. Lattanzi S, et al. Epilepsia. 2023 Nov;64(11):2922-2933. doi: 10.1111/epi.17740. Epub 2023 Sep 9. Epilepsia. 2023. PMID: 38079181 Free article.
Oral Misoprostol for the Induction of Labor: Comparison of Different Dosage Schemes With Respect to Maternal and Fetal Outcome in Patients Beyond 34 Weeks of Pregnancy.
Ratiu O, Ratiu D, Mallmann P, DI Liberto A, Ertan AK, Morgenstern B, Mallmann MR, Ludwig S, Grüttner B, Eichler C, Thangarajah F, Gilman E, Abel JS. Ratiu O, et al. Among authors: di liberto a. In Vivo. 2022 May-Jun;36(3):1285-1289. doi: 10.21873/invivo.12828. In Vivo. 2022. PMID: 35478103 Free PMC article.
25 results